CG:603707 Nanjing King-Friend Biochemical Ph

Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd manufactures and sells heparin sodium and low molecular weight heparin products for pharmaceutical companies in the People's Republic of China. It offers enoxaparin sodium, dalteparin sodium, and naqu heparin calcium injections. The company also exports its products primarily to the European and American countries. The company was founded in 2000 and is based in Nanjing, the People's Republic of China.

36.45 CNY
As of 01/27/2022

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  07/19/2017
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   45,727,170,560 CNY
Current dividend yield:   0.31%
Sedol:      BF2DZL7

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy